TEM Quote, Financials, Valuation and Earnings

Bullfrog AI Holdings has a net margin of -6.49% compared to Tempus AI's net margin of --. Tempus AI's return on equity of -- beat Bullfrog AI Holdings's return on equity of --.

Tempus AI has a consensus price target of $61.40, signalling upside risk potential of 16.07%. On the other hand Bullfrog AI Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that Tempus AI has higher upside potential than Bullfrog AI Holdings, analysts believe Tempus AI is more attractive than Bullfrog AI Holdings.

Tempus AI has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Bullfrog AI Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Tempus AI has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Bullfrog AI Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tempus AI pays -0.8% of its earnings as a dividend. Bullfrog AI Holdings pays out -- of its earnings as a dividend.

Tempus AI quarterly revenues are $200.7M, which are larger than Bullfrog AI Holdings quarterly revenues of --. Tempus AI's net income of -$13M is lower than Bullfrog AI Holdings's net income of -$1.7M. Notably, Tempus AI's price-to-earnings ratio is -- while Bullfrog AI Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tempus AI is 10.98x versus -- for Bullfrog AI Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Doximity has a net margin of -6.49% compared to Tempus AI's net margin of 44.6%. Tempus AI's return on equity of -- beat Doximity's return on equity of 21.55%.

Tempus AI has a consensus price target of $61.40, signalling upside risk potential of 16.07%. On the other hand Doximity has an analysts' consensus of $71.82 which suggests that it could grow by 26.79%. Given that Doximity has higher upside potential than Tempus AI, analysts believe Doximity is more attractive than Tempus AI.

Tempus AI has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Doximity has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Tempus AI has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Doximity offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tempus AI pays -0.8% of its earnings as a dividend. Doximity pays out -- of its earnings as a dividend.

Tempus AI quarterly revenues are $200.7M, which are larger than Doximity quarterly revenues of $168.6M. Tempus AI's net income of -$13M is lower than Doximity's net income of $75.2M. Notably, Tempus AI's price-to-earnings ratio is -- while Doximity's PE ratio is 56.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tempus AI is 10.98x versus 20.67x for Doximity. Usually stocks with elevated PS ratios are considered overvalued.

FOXO Technologies has a net margin of -6.49% compared to Tempus AI's net margin of -162.71%. Tempus AI's return on equity of -- beat FOXO Technologies's return on equity of --.

Tempus AI has a consensus price target of $61.40, signalling upside risk potential of 16.07%. On the other hand FOXO Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that Tempus AI has higher upside potential than FOXO Technologies, analysts believe Tempus AI is more attractive than FOXO Technologies.

Tempus AI has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison FOXO Technologies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Tempus AI has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. FOXO Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tempus AI pays -0.8% of its earnings as a dividend. FOXO Technologies pays out -- of its earnings as a dividend.

Tempus AI quarterly revenues are $200.7M, which are larger than FOXO Technologies quarterly revenues of $1.2M. Tempus AI's net income of -$13M is lower than FOXO Technologies's net income of -$1.9M. Notably, Tempus AI's price-to-earnings ratio is -- while FOXO Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tempus AI is 10.98x versus 0.29x for FOXO Technologies. Usually stocks with elevated PS ratios are considered overvalued.

GE HealthCare Technologies has a net margin of -6.49% compared to Tempus AI's net margin of 13.56%. Tempus AI's return on equity of -- beat GE HealthCare Technologies's return on equity of 24.88%.

Tempus AI has a consensus price target of $61.40, signalling upside risk potential of 16.07%. On the other hand GE HealthCare Technologies has an analysts' consensus of $97.01 which suggests that it could grow by 41.78%. Given that GE HealthCare Technologies has higher upside potential than Tempus AI, analysts believe GE HealthCare Technologies is more attractive than Tempus AI.

Tempus AI has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison GE HealthCare Technologies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Tempus AI has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GE HealthCare Technologies offers a yield of 0.19% to investors and pays a quarterly dividend of $0.04 per share. Tempus AI pays -0.8% of its earnings as a dividend. GE HealthCare Technologies pays out 2.76% of its earnings as a dividend. GE HealthCare Technologies's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Tempus AI quarterly revenues are $200.7M, which are smaller than GE HealthCare Technologies quarterly revenues of $5.3B. Tempus AI's net income of -$13M is lower than GE HealthCare Technologies's net income of $721M. Notably, Tempus AI's price-to-earnings ratio is -- while GE HealthCare Technologies's PE ratio is 15.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tempus AI is 10.98x versus 1.60x for GE HealthCare Technologies. Usually stocks with elevated PS ratios are considered overvalued.